Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali.

about

Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial.

P2860

Q36265027-51A9E8B1-28BB-44DA-8082-72E90453E235 Q37176794-C7C4EF60-D700-4920-A305-7E46E77CFE50

P2860

Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali.

Item

http://www.wikidata.org/entity/Q36265080

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Population-Level Persistence o ...... -Vaccination Campaign in Mali.

@ast

Population-Level Persistence o ...... -Vaccination Campaign in Mali.

@en

type

Item

label

Population-Level Persistence o ...... -Vaccination Campaign in Mali.

@ast

Population-Level Persistence o ...... -Vaccination Campaign in Mali.

@en

prefLabel

Population-Level Persistence o ...... -Vaccination Campaign in Mali.

@ast

Population-Level Persistence o ...... -Vaccination Campaign in Mali.

@en

P1476

Population-Level Persistence o ...... -Vaccination Campaign in Mali.

@en

P2093

Abdoulaye Berthe

http://www.w3.org/2001/XMLSchema#string

Awa Traoré Eps Dembélé

http://www.w3.org/2001/XMLSchema#string

Helen Findlow

http://www.w3.org/2001/XMLSchema#string

Kelly Townsend

http://www.w3.org/2001/XMLSchema#string

Lesley Mabey

http://www.w3.org/2001/XMLSchema#string

Nicole E Basta

http://www.w3.org/2001/XMLSchema#string

Rahamatou M Boukary

http://www.w3.org/2001/XMLSchema#string

Xilian Bai

http://www.w3.org/2001/XMLSchema#string

P2860

Polysaccharide vaccines for preventing serogroup A meningococcal meningitis

Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.

Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine.

Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).

Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis.

Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.

P304

S547-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIV602

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

61 Suppl 5

http://www.w3.org/2001/XMLSchema#string

P50

Uma Onwuchekwa

Ray Borrow

Samba Sow

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26553687

http://www.w3.org/2001/XMLSchema#string

P921

Mali

P932

4639504

http://www.w3.org/2001/XMLSchema#string

Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali.

about

P2860

P2860

Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932